This study is a multicentre, open label (participants know their treatment) trial. Patients with FIGO stage III epithelial ovarian cancer, eligible for surgery to reduce the amount of cancer in their body, will be included. They will be randomised to receive surgery with or without hyperthermic intraperitoneal chemotherapy (where a dose of heated chemotherapy is provided after surgery).
| Study Type: | Clinical Trial |
| Clinical Area: | Oncology |
| Condition: | Ovarian Cancer |
| Principal Investigator: | Professor Donal Brennan |
| Study Coordinator: | Laura Helbert |
| Key Eligibility Criteria: | Age 18 years. stage III primary epithelial ovarian, fallopian tube, or extra-ovarian cancer, treated with primary complete cytoreduction, |
| Contact Email: | lhelbert@mater.ie |